Immune responses induced in cattle by vaccination with a recombinant adenovirus expressing mycobacterial antigen 85A and Mycobacterium bovis BCG

Infection and Immunity

Volumn 74, Issue 2, 2006, Pages 1416-1418

  Vordermeier, H Martin ^a,e   Huygen, Kris ^b   Singh, Mahavir ^c   Hewinson, R Glyn ^a   Xing, Zhou ^d  

^a VETERINARY LABORATORIES AGENCY   (United Kingdom)

^b PASTEUR INSTITUTE OF BRUSSELS   (Belgium)

^c LIONEX DIAGNOSTICS AND THERAPEUTICS GMBH   (Germany)

^d MCMASTER UNIVERSITY   (Canada)

^e TB Research Group   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; GAMMA INTERFERON; MYCOBACTERIUM ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CATTLE; CATTLE DISEASE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; IMMUNE RESPONSE; INFECTION CONTROL; MEMORY CELL; MYCOBACTERIUM BOVIS; NONHUMAN; PRIORITY JOURNAL; TUBERCULOSIS; VACCINATION; VIRUS EXPRESSION; VIRUS INDUCTION; VIRUS RECOMBINANT; VIRUS REPLICATION;

ADENOVIRIDAE; ANIMALS; ANTIGENS, BACTERIAL; BCG VACCINE; CATTLE; IMMUNIZATION SCHEDULE; IMMUNIZATION, SECONDARY; INTERFERON TYPE II; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; MYCOBACTERIUM BOVIS; TUBERCULOSIS, BOVINE; VACCINATION;

EID: 31844433211     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.74.2.1416-1418.2006     Document Type: Article

References (19)

1. Brandt, L., J. Feino Cunha, A. Weinreich Olsen, B. Chilima, P. Hirsch, R. Appelberg, and P. Andersen. 2002. Failure of the Mycobacterium bovis BCG vaccine: some species of environmental mycobacteria block multiplication of BCG and induction of protective immunity to tuberculosis. Infect. Immun. 70:672-678.
2. Feng, C. G., U. Palendira, C. Demangel, J. M. Spratt, A. S. Malin, and W. J. Britton. 2001. Priming by DNA immunization augments protective efficacy of Mycobacterium bovis bacillus Calmette-Guerin against tuberculosis. Infect. Immun. 69:4174-4176.
3. Fine, P. E. 1989. The BCG story: lessons from the past and implications for the future. Rev. Infect. Dis. 11(Suppl. 2):S353-S359.
4. Godkin, A. J., H. C. Thomas, and P. J. Openshaw. 2002. Evolution of epitope-specific memory CD4(+) T cells after clearance of hepatitis C virus. J. Immunol. 169:2210-2214.
5. Goonetilleke, N. P., H. McShane, C. M. Hannan, R. J. Anderson, R. H. Brookes, and A. V. Hill. 2003. Enhanced immunogenicity and protective efficacy against Mycobacterium tuberculosis of bacille Calmette-Guerin vaccine using mucosal administration and boosting with a recombinant modified vaccinia virus Ankara. J. Immunol. 171:1602-1609.
6. Hewinson, R. G., H. M. Vordermeier, and B. M. Buddle. 2003. Use of the bovine model of tuberculosis for the development of improved vaccines and diagnostics. Tuberculosis 83:119-130.
7. Krebs, J. R. 1997. Bovine tuberculosis in cattle and badgers. Ministry of Agriculture, Fisheries and Food Publications, London, United Kingdom.
8. + T-cell responses and protective efficacy of a DNA-modified vaccinia virus Ankara prime-boost vaccination regimen for murine tuberculosis. Infect. Immun. 69:681-686.
9. McShane, H., A. A. Pathan, C. R. Sander, N. P. Goonetilleke, H. A. Fletcher, and A. V. Hill. 2005. Boosting BCG with MVA85A: the first candidate subunit vaccine for tuberculosis in clinical trials. Tuberculosis (Edinburgh) 85:47-52.
10. McShane, H., A. A. Pathan, C. R. Sander, S. M. Keating, S. C. Gilbert, K. Huygen, H. A. Fletcher, and A. V. Hill. 2004. Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans. Nat. Med. 10:1240-1244.
11. Reece, W. H., M. Pinder, P. K. Gothard, P. Milligan, K. Bojang, T. Doherty, M. Plebanski, P. Akinwunmi, S. Everaere, K. R. Watkins, G. Voss, N. Tornieporth, A. Alloueche, B. M. Greenwood, K. E. Kester, K. P. McAdam, J. Cohen, and A. V. Hill. 2004. A CD4(+) T-cell immune response to a conserved epitope in the circumsporozoite protein correlates with protection from natural Plasmodium falciparum infection and disease. Nat. Med. 10:406-410.
12. Santosuosso, M., X. Zhang, S. McCormick, J. Wang, M. Hitt, and Z. Xing. 2005. Mechanisms of mucosal and parenteral tuberculosis vaccinations: adenoviral-based mucosal immunization preferentially elicits sustained accumulation of immune protective CD4 and CD8 T cells within the airway lumen. J. Immunol. 174:7986-7994.
13. Skinner, M., B. M. Buddle, N. Wedlock, D. Keen, G. W. de Lisle, R. E. Tascon, J. C. Ferraz, D. B. Lowrie, P. J. Cockle, H. M. Vordermeier, and R. G. Hewinson. 2003. A DNA prime-BCG boost vaccination strategy in cattle induces protection against bovine tuberculosis. Infect. Immun. 71:4901-4907.
14. Vordermeier, H. M., M. A. Chambers, P. J. Cockle, A. O. Whelan, J. Simmons, and R. G. Hewinson. 2002. Correlation of ESAT-6-specific gamma Interferon production with pathology in cattle following Mycobacterium bovis BCG vaccination against experimental bovine tuberculosis. Infect. Immun. 70:3026-3032.
15. Vordermeier, H. M., P. C. Cockle, A. Whelan, S. Rhodes, N. Palmer, D. Bakker, and R. G. Hewinson. 1999. Development of diagnostic reagents to differentiate between Mycobacterium bovis BCG vaccination and M. bovis infection in cattle. Clin. Diagn. Lab. Immunol. 6:675-682.
16. Vordermeier, H. M., S. G. Rhodes, G. Dean, N. Goonetilleke, K. Huygen, A. V. Hill, R. G. Hewinson, and S. C. Gilbert 2004. Cellular immune responses induced in cattle by heterologous prime-boost vaccination using recombinant viruses and bacille Calmette-Guerin. Immunology 112:461-470.
17. Wang, J., L. Thorson, R. W. Stokes, M. Santosuosso, K. Huygen, A. Zganiacz, M. Hitt, and Z. Xing. 2004. Single mucosal, but not parenteral, immunization with recombinant adenoviral-based vaccine provides potent protection from pulmonary tuberculosis. J. Immunol. 173:6357-6365.
18. Wherry, E. J., V. Teichgraber, T. C. Becker, D. Masopust, S. M. Kaech, R. Antia, U. H. von Andrian, and R. Ahmed. 2003. Lineage relationship and protective immunity of memory CD8 T cell subsets. Nat. Immunol. 4:225-234.
19. Williams, A., G. J. Hatch, S. O. Clark, K. E. Gooch, K. A. Hatch, G. A. Hall, K. Huygen, T. H. Ottenhoff, K. L. Franken, P. Andersen, T. Mark Doherty, S. H. Kaufmann, L. Grade, P. Seiler, C. Martin, B. Gicquel, S. T. Cole, P. Brodin, A. S. Pym, W. Dalemans, J. Cohen, Y. Lobet, N. Goonetilleke, H. McShane, A. Hill, T. Parish, D. Smith, N. G. Stoker, D. B. Lowrie, G. Kallenius, S. Svenson, A. Pawlowski, K. Blake, and P. D. Marsh. 2005. Evaluation of vaccines in the EU TB Vaccine Cluster using a guinea pig aerosol infection model of tuberculosis. Tuberculosis (Edinburgh) 85:29-38.